GSK application to expand use of Nucala for COPD accepted for review by EMA Ruchika Sharma25 March 2025 1:30 PM ISTIL-5 is a key cytokine (protein) in type 2 inflammation which is an underlying driver in many diseases.
Pfizer to exit Haleon Ruchika Sharma19 March 2025 6:30 PM ISTBengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the...
GSK Pharma names Carson Dalton as Executive Vice President, Communications and Government Affairs Ruchika Sharma4 March 2025 3:12 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, Communications...
USFDA accepts GSK depemokimab applications for review for asthma, chronic rhinosinusitis Ruchika Sharma4 March 2025 12:30 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of...
GSK buys IDRx for up to USD 1.15 billion Ruchika Sharma25 Feb 2025 2:33 PM ISTLondon: GSK plc has announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated...
Dr Gavin Screaton to join Board of GSK as Non-Executive Director Ruchika Sharma24 Feb 2025 12:48 PM ISTOn appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility Committee.
GSK Nucala application for COPD accepted for review in China Ruchika Sharma23 Feb 2025 12:30 PM ISTGSK plc has announced that the China National Medical Products Administration has accepted for review the new drug application for the use of...
FDA Approves GSK's Pentavalent Meningococcal Vaccine Dr. Kamal Kant Kohli18 Feb 2025 9:00 PM ISTThe US Food and Drug Administration (FDA) has approved GSK's pentavalent meningococcal vaccine, Penmenvy, for children and young adults aged 10 to 25...
GSK's Meningococcal Vaccine Penmenvy Approved by USFDA Farhat Nasim17 Feb 2025 5:19 PM ISTBengaluru: The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for...
GSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs Farhat Nasim16 Feb 2025 11:45 AM ISTBengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its...
European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescents Ruchika Sharma2 Feb 2025 1:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP Ruchika Sharma2 Feb 2025 11:30 AM ISTGSK plc has announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to...
